Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Open Forum Infectious Diseases
|
February 19, 2019
Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
Jacqueline M McBride, Daniel Sheinson, Jenny Jiang, et al.
Therapeutic Advances in Respiratory Disease
|
November 29, 2025
Randomized, phase I studies to evaluate the safety, tolerability, and pharmacokinetics of an inhaled, TMEM16A potentiator, GDC-6988, in healthy subjects
Paul Miller, Daniel Repplinger, Rui Zhu, et al.
Antimicrobial Agents and Chemotherapy
|
March 27, 2019
A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-<i>Staphylococcus aureus</i> Thiomab Antibody-Antibiotic Conjugate, in Healthy Volunteers
Melicent Peck, Michael E Rothenberg, Rong Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2020
Antibody-mediated activation of the FGFR1/Klothoβ complex corrects metabolic dysfunction and alters food preference in obese humans
Amos Baruch, Chin Wong, Leslie W Chinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Suppression of HER2/HER3-mediated growth of breast cancer cells with combinations of GDC-0941 PI3K inhibitor, trastuzumab, and pertuzumab
Evelyn Yao, Wei Zhou, Si Tuen Lee-Hoeflich, et al.
Plos Pathogens
|
April 12, 2014
A neutralizing anti-gH/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infection
Marcy R Auerbach, Donghong Yan, Rajesh Vij, et al.
Science Translational Medicine
|
September 23, 2011
A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis
Kasia Owczarczyk, Preeti Lal, Alexander R Abbas, et al.
Open Forum Infectious Diseases
|
April 27, 2019
Sustained Circulating Bacterial Deoxyribonucleic Acid Is Associated With Complicated <i>Staphylococcus aureus</i> Bacteremia
Johnny Gutierrez, Alessander O Guimaraes, Nicholas Lewin-Koh, et al.
Clinical and Translational Science
|
June 23, 2023
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteers
Fei Tang, Rebecca Kunder, Tom Chu, et al.
The Journal of Allergy and Clinical Immunology
|
July 31, 2016
Peripheral blood gene expression predicts clinical benefit from anti-IL-13 in asthma
David F Choy, Guiquan Jia, Alexander R Abbas, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Open Forum Infectious Diseases
|
February 19, 2019
Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
Jacqueline M McBride, Daniel Sheinson, Jenny Jiang, et al.
Therapeutic Advances in Respiratory Disease
|
November 29, 2025
Randomized, phase I studies to evaluate the safety, tolerability, and pharmacokinetics of an inhaled, TMEM16A potentiator, GDC-6988, in healthy subjects
Paul Miller, Daniel Repplinger, Rui Zhu, et al.
Antimicrobial Agents and Chemotherapy
|
March 27, 2019
A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-<i>Staphylococcus aureus</i> Thiomab Antibody-Antibiotic Conjugate, in Healthy Volunteers
Melicent Peck, Michael E Rothenberg, Rong Deng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2020
Antibody-mediated activation of the FGFR1/Klothoβ complex corrects metabolic dysfunction and alters food preference in obese humans
Amos Baruch, Chin Wong, Leslie W Chinn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Suppression of HER2/HER3-mediated growth of breast cancer cells with combinations of GDC-0941 PI3K inhibitor, trastuzumab, and pertuzumab
Evelyn Yao, Wei Zhou, Si Tuen Lee-Hoeflich, et al.
Plos Pathogens
|
April 12, 2014
A neutralizing anti-gH/gL monoclonal antibody is protective in the guinea pig model of congenital CMV infection
Marcy R Auerbach, Donghong Yan, Rajesh Vij, et al.
Science Translational Medicine
|
September 23, 2011
A plasmablast biomarker for nonresponse to antibody therapy to CD20 in rheumatoid arthritis
Kasia Owczarczyk, Preeti Lal, Alexander R Abbas, et al.
Open Forum Infectious Diseases
|
April 27, 2019
Sustained Circulating Bacterial Deoxyribonucleic Acid Is Associated With Complicated <i>Staphylococcus aureus</i> Bacteremia
Johnny Gutierrez, Alessander O Guimaraes, Nicholas Lewin-Koh, et al.
Clinical and Translational Science
|
June 23, 2023
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteers
Fei Tang, Rebecca Kunder, Tom Chu, et al.
The Journal of Allergy and Clinical Immunology
|
July 31, 2016
Peripheral blood gene expression predicts clinical benefit from anti-IL-13 in asthma
David F Choy, Guiquan Jia, Alexander R Abbas, et al.
Page
of 3